AI-Driven Cavitation-Enhanced Drug Treatment Planning

An improved system and method for simulating and adjusting cavitation-enhanced drug-treatment procedures using artificial intelligence, patient-specific anatomical data, and real-time monitoring to optimize treatment outcomes and minimize risks.

The original patent disclosed a system for simulating and adjusting cavitation-enhanced drug-treatment procedures, but it had limitations in terms of predicting optimal sonication parameters, minimizing damage to non-target tissue, and ensuring real-time monitoring and adjustment. The new inventive concept addresses these limitations by integrating artificial intelligence, patient-specific anatomical data, and real-time monitoring to improve the safety and efficacy of the treatment procedure.

The new inventive concept utilizes artificial intelligence to predict optimal sonication parameters based on patient-specific anatomical data, enabling personalized treatment planning. The system also includes a real-time monitoring component that detects changes in tissue permeability and adjusts the sonication parameters accordingly. Additionally, the system can identify a safety threshold associated with the target BBB region and adjust the treatment protocol to avoid exceeding it. The new inventive concept also includes a method for optimizing a microbubble-enhanced ultrasound procedure for targeted drug delivery, comprising identifying a target tumor region and a target BBB region, and adjusting the ultrasound frequency and amplitude to minimize damage to non-target tissue.

The new inventive concept's use of artificial intelligence, patient-specific anatomical data, and real-time monitoring to optimize treatment outcomes and minimize risks is a novel and non-obvious improvement over the original patent. The integration of these components provides a more efficient, safer, and more effective treatment procedure.

Alternative embodiments of the new inventive concept could include using different machine learning algorithms, incorporating additional patient-specific data, or integrating with other medical imaging modalities. Variations of the system could include using different types of sensors for real-time monitoring or adjusting the treatment protocol based on different safety thresholds.

The new inventive concept has significant commercial potential in the pharmaceutical and medical device industries, particularly in the areas of targeted drug delivery and cancer treatment. The improved safety and efficacy of the treatment procedure could lead to increased adoption and market share.